BioSpace News Archive

Crestone, Inc. today announced a contract award from the National Institutes of Health for the advancement of its antibiotic candidate CRS0540 to treat infections caused by drug-resistant Gram-positive bacteria. The lead compound CRS0540 has demonstrated efficacy in several mouse models of infection including MRSA soft tissue and blood stream infections, pneumococcal lung infection, and even an inhalational anthrax ch

PanTheryx, the world’s largest colostrum-based nutrition and biotechnology company, announced today the appointment of Tom Feeley to the position of Chief Financial Officer (CFO). Mr. Feeley began his role with PanTheryx on June 22 and reports to President and Chief Executive Officer Wes Parris. Mr. Feeley will be responsible for the development and execution of PanTheryx’s financial strategy including all Finance, Account

Dow (NYSE: DOW) today announced its MobilityScience™ platform designed to enhance the customer experience by tailoring technologies, products, and services from across Dow businesses to the transportation industry.

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the first patient with triple negative breas

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, today announced that 17 abstracts highlighting PyL™ (18F-DCFPyL) have been selected for presentation at the virtual Society of Nuclear Medicine and Molecular Imaging

On April 1, a dozen anesthesiology resident physicians from Massachusetts General Hospital kicked off an audacious public challenge to design a rapidly deployable, minimum viable ventilator that could address shortages caused by the COVID-19 pandemic, particularly in developing countries.

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Elizabeth Tallett has joined its Board of Directors. Ms. Tallett was also appointed to serve on the Audit Committee of the Board. With

Based on internal data, 29% of nursing home employees tested positive for antibodies Since the beginning of the COVID-19 pandemic, BioReference has performed 222,000 COVID-19 PCR and 3,500 antibody tests in over 350 facilities

Quantabio , a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced that its UltraPlex 1-Step ToughMix was recognized as part of the expanded emergency use authorization (EUA)

Ipsen presents Phase I/II clinical data evaluating liposomal irinotecan (Onivyde ® ) as an investigational first-line combination treatment for metastatic pancreatic cancer at the ESMO World Congress on Gastrointestinal Cancer Ipsen has initiated the NAPOLI-3 Phase III clinical study (NCT04083235) comparing the safety and efficacy of liposomal irinotecan + 5-fluorouracil/leucovorin (5-FU/LV) + oxaliplatin (OX) (NALIRIFOX) to gemcitabine + nab-paclitaxel in the f